COM:ALDEYRA
Aldeyra Therapeutics, Inc.
- Stock
Last Close
4.81
22/11 21:00
Market Cap
202.01M
Beta: -
Volume Today
652.02K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | -1.62M - | -1.62M 0% | ||||||||||
average payables | 207.20K - | 341.57K 64.86% | 596.23K 74.55% | 563.30K 5.52% | 638.20K 13.30% | 2.03M 217.50% | 1.93M 4.75% | 594.97K 69.17% | 700.67K 17.77% | 576.66K 17.70% | 735.84K 27.60% | |
average receivables | 375.22K - | 1.62M - | 1.62M 0% | |||||||||
book value per share | 4.93 - | 1.65 66.64% | 2.88 75.08% | 1.91 33.82% | 2.49 30.42% | 3.99 60.59% | 1.77 55.60% | 1.75 1.21% | 3.81 117.29% | 2.59 32.08% | 2.03 21.39% | |
capex per share | -0.00 - | -0.01 170.83% | -0.00 89.57% | -0.00 49.48% | -0.01 679.81% | -0.00 97.10% | -0.00 - | -0.00 93.41% | ||||
capex to depreciation | -13.15 - | -4.59 65.14% | -0.33 92.81% | -0.65 98.25% | -3.70 466.17% | -0.10 97.33% | -0.03 - | -0.06 113.45% | ||||
capex to operating cash flow | 0.00 - | 0.01 214.11% | 0.00 91.57% | 0.00 65.20% | 0.01 583.81% | 0.00 97.59% | 0.00 - | 0.00 57.06% | ||||
capex to revenue | ||||||||||||
cash per share | 9.97 - | 2.23 77.59% | 3.20 43.09% | 2.19 31.33% | 2.70 22.91% | 4.32 60.02% | 2.71 37.31% | 2.29 15.29% | 4.25 85.50% | 2.98 29.82% | 2.42 18.81% | |
days of inventory on hand | ||||||||||||
days payables outstanding | ||||||||||||
days sales outstanding | ||||||||||||
debt to assets | 0.34 - | 0.14 58.04% | 0.05 67.95% | 0.05 14.35% | 0.03 42.10% | 0.20 - | 0.18 5.88% | 0.07 63.01% | 0.09 30.43% | 0.11 18.98% | ||
debt to equity | 0.79 - | 0.20 74.69% | 0.05 74.02% | 0.06 17.35% | 0.03 44.49% | 0.31 - | 0.26 16.06% | 0.08 70.07% | 0.11 38.18% | 0.13 22.71% | ||
dividend yield | ||||||||||||
earnings yield | 5.54 - | -0.19 103.40% | -0.21 9.76% | -0.31 49.07% | -0.21 32.98% | -0.22 4.72% | -0.39 78.70% | -0.16 58.26% | -0.27 70.08% | -0.15 44.92% | -0.18 20.20% | |
enterprise value | 366.85K - | 20.29M 5,431.65% | 45.18M 122.63% | 50.04M 10.75% | 89.58M 79.04% | 132.63M 48.06% | 127.85M 3.61% | 170.48M 33.34% | 2.24M 98.69% | 278.17M 12,340.70% | 79.72M 71.34% | |
enterprise value over ebitda | -0.10 - | -2.79 2,697.08% | -3.77 35.14% | -2.69 28.65% | -4.03 49.77% | -3.42 15.07% | -2.33 32.05% | -4.97 113.56% | -0.04 99.20% | -4.61 11,454.75% | -1.86 59.59% | |
ev to operating cash flow | -0.21 - | -4.25 1,876.62% | -4.85 14.19% | -3.30 31.92% | -4.66 41.08% | -4.44 4.68% | -2.84 36.02% | -4.55 59.98% | -0.05 98.84% | -4.91 9,247.67% | -2.63 46.47% | |
ev to sales | ||||||||||||
free cash flow per share | -5.21 - | -1.25 75.93% | -1.09 13.24% | -1.34 22.68% | -1.21 9.47% | -1.39 14.90% | -1.66 19.48% | -1.10 33.49% | -0.79 28.65% | -0.97 23.16% | -0.51 46.96% | |
free cash flow yield | -0.72 - | -0.17 76.00% | -0.16 7.61% | -0.25 55.47% | -0.18 28.78% | -0.17 5.87% | -0.29 70.69% | -0.16 43.67% | -0.20 22.37% | -0.14 29.22% | -0.15 5.18% | |
graham net net | 3.46 - | 1.58 54.45% | 2.81 78.12% | 1.88 33.00% | 2.41 28.00% | 3.93 62.88% | 1.69 56.85% | 1.59 6.13% | 3.75 135.50% | 2.48 33.79% | 1.94 21.80% | |
graham number | 66.54 - | 7.09 89.34% | 9.53 34.33% | 8.41 11.77% | 8.86 5.40% | 12.70 43.27% | 9.46 25.47% | 6.60 30.23% | 9.69 46.79% | 7.82 19.33% | 5.40 30.97% | |
income quality | -0.13 - | 0.92 804.62% | 0.77 16.35% | 0.81 5.18% | 0.86 6.22% | 0.77 10.78% | 0.74 3.66% | 1.00 35.00% | 0.74 26.23% | 0.91 23.97% | 0.81 11.54% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -23.08 - | -29.78 29.04% | -106.75 258.52% | -177.20 65.99% | -198.22 11.86% | -270.44 36.44% | -104.45 61.38% | -19.13 81.69% | -32.27 68.72% | -37.00 14.65% | 20.66 155.84% | |
interest debt per share | 4.37 - | 0.39 91.03% | 0.16 58.61% | 0.13 22.83% | 0.09 27.28% | 0.01 92.57% | 0.57 8,268.67% | 0.51 10.44% | 0.33 35.80% | 0.30 6.54% | 0.23 24.28% | |
inventory turnover | ||||||||||||
invested capital | 0.79 - | 0.20 74.69% | 0.05 74.02% | 0.06 17.35% | 0.03 44.49% | 0.31 - | 0.26 16.06% | 0.08 70.07% | 0.11 38.18% | 0.13 22.71% | ||
market cap | 2.36M - | 27.57M 1,069.57% | 58.54M 112.35% | 60.73M 3.75% | 108.27M 78.27% | 179.99M 66.24% | 157.52M 12.48% | 233.01M 47.92% | 216.17M 7.23% | 406.51M 88.05% | 206.89M 49.11% | |
net current asset value | 1.14M - | 6.26M 447.70% | 24.76M 295.76% | 21.59M 12.80% | 39.39M 82.42% | 86.30M 119.07% | 47.73M 44.69% | 59.22M 24.06% | 205.35M 246.79% | 150.74M 26.59% | 119.28M 20.87% | |
net debt to ebitda | 0.54 - | 1.00 84.82% | 1.12 11.48% | 0.58 48.41% | 0.84 46.11% | 1.22 45.38% | 0.54 55.83% | 1.82 237.54% | 3.82 109.53% | 2.13 44.28% | 2.97 39.69% | |
net income per share | 39.90 - | -1.36 103.41% | -1.40 3.07% | -1.65 17.63% | -1.40 14.82% | -1.79 27.82% | -2.24 25.09% | -1.11 50.72% | -1.10 0.83% | -1.05 4.17% | -0.64 39.38% | |
operating cash flow per share | -5.21 - | -1.25 76.01% | -1.08 13.78% | -1.33 23.72% | -1.21 9.52% | -1.38 14.04% | -1.66 20.51% | -1.10 33.47% | -0.79 28.66% | -0.97 23.15% | -0.51 46.94% | |
payables turnover | ||||||||||||
receivables turnover | ||||||||||||
research and ddevelopement to revenue | ||||||||||||
return on tangible assets | 3.49 - | -0.59 116.92% | -0.43 27.39% | -0.74 73.19% | -0.51 31.88% | -0.41 19.12% | -0.81 96.93% | -0.45 44.06% | -0.25 43.59% | -0.34 33.19% | -0.25 25.23% | |
revenue per share | ||||||||||||
roe | 8.09 - | -0.83 110.21% | -0.49 41.13% | -0.86 77.73% | -0.56 34.68% | -0.45 20.41% | -1.27 181.74% | -0.63 50.12% | -0.29 54.36% | -0.41 41.10% | -0.31 22.89% | |
roic | -1.26 - | -1.01 19.72% | -0.46 54.66% | -0.82 78.42% | -0.55 32.09% | -0.47 15.37% | -0.98 108.52% | -0.48 51.07% | -0.26 45.77% | -0.37 42.66% | -0.31 15.07% | |
sales general and administrative to revenue | ||||||||||||
shareholders equity per share | 4.93 - | 1.65 66.64% | 2.88 75.08% | 1.91 33.82% | 2.49 30.42% | 3.99 60.59% | 1.77 55.60% | 1.75 1.21% | 3.81 117.29% | 2.59 32.08% | 2.03 21.39% | |
stock based compensation to revenue | ||||||||||||
tangible asset value | 1.61M - | 6.28M 289.14% | 24.88M 295.90% | 21.65M 12.98% | 39.60M 82.92% | 86.62M 118.73% | 48.08M 44.49% | 59.51M 23.76% | 205.74M 245.72% | 151.01M 26.60% | 119.80M 20.67% | |
tangible book value per share | 4.93 - | 1.65 66.64% | 2.88 75.08% | 1.91 33.82% | 2.49 30.42% | 3.99 60.59% | 1.77 55.60% | 1.75 1.21% | 3.81 117.29% | 2.59 32.08% | 2.03 21.39% | |
working capital | 2.67M - | 7.43M 178.81% | 25.97M 249.46% | 22.83M 12.09% | 40.61M 77.87% | 86.30M 112.49% | 62.26M 27.85% | 70.65M 13.47% | 220.98M 212.78% | 165.66M 25.03% | 125.55M 24.21% |
All numbers in USD (except ratios and percentages)